Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.

@article{Pengo2004IncidenceOC,
  title={Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism.},
  author={Vittorio Pengo and Anthonie W. A. Lensing and Martin H. Prins and Antonio Marchiori and Bruce L. Davidson and Francesca Tiozzo and Paolo Albanese and Alessandra Biasiolo and Cinzia Pegoraro and Sabino Iliceto and Paolo Prandoni},
  journal={The New England journal of medicine},
  year={2004},
  volume={350 22},
  pages={
          2257-64
        }
}
BACKGROUND Chronic thromboembolic pulmonary hypertension (CTPH) is associated with considerable morbidity and mortality. Its incidence after pulmonary embolism and associated risk factors are not well documented. METHODS We conducted a prospective, long-term, follow-up study to assess the incidence of symptomatic CTPH in consecutive patients with an acute episode of pulmonary embolism but without prior venous thromboembolism. Patients with unexplained persistent dyspnea during follow-up… 
Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.
TLDR
CTEPH was not rare after acute PE in this Chinese population, especially within 3 years of diagnosis, but lower-limb varicose veins, intermediate-risk PE with elevated SPAP in the acute phase, and residual emboli during follow-up might increase the risk of CTEPH.
[Incidence of symptomatic and asymptomatic chronic thromboembolic pulmonary hypertension].
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism.
TLDR
The incidence of chronic thromboembolic pulmonary hypertension after the first episode of objectively confirmed pulmonary embolism was about 1%, and a diagnosis of CTPH was confirmed in two patients with idiopathic PE.
From acute pulmonary embolism to chronic thromboembolic pulmonary hypertension.
  • V. Pengo, P. Prandoni
  • Medicine
    Italian heart journal : official journal of the Italian Federation of Cardiology
  • 2005
Chronic thromboembolic pulmonary hypertension (CTEPH), a disease associated with considerable morbidity and mortality, is the consequence of unresolved thromboembolic occlusion in pulmonary
The incidence of chronic thromboembolic pulmonary hypertension secondary to acute pulmonary thromboembolism.
TLDR
Potentially preventabl complication of pulmonary embolism; CTEPH, had a substantial incidence during follow-up, and the univariate analysis showed no association between the development ofCTEPH and factors like; age, etiologic risk factors for PTE, receiving thrombolytic treatment, prevalence and type of PTE.
Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension.
TLDR
A case-control-study comparing 109 consecutive CTEPH patients to 187 patients with acute pulmonary embolism confirmed by a high probability lung scan found that splenectomy, ventriculo-atrial shunt for the treatment of hydrocephalus, and chronic inflammatory disorders, such as osteomyelitis and inflammatory bowel disease, were associated with an increased risk ofCTEPH.
Evaluation of the Incidence of Chronic Thromboembolic Pulmonary Hypertension 1 Year After First Episode of Acute Pulmonary Embolism: A Cohort Study
TLDR
The incidence of Chronic thromboembolic pulmonary hypertension observed in this study 1 year after the first episode of acute PE was approximately 6.9%.
Chronic thromboembolic pulmonary hypertension after the first episode of pulmonary embolism? How often?
TLDR
Patients at risk of CTEPH can be identified for effective follow-up according to echocardiographic finding of elevated pulmonary artery systolic pressure and NT-proBNP levels at the time of hospital discharge.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis.
TLDR
It is hypothesized that in situ thrombosis and pulmonary arteriopathy are common causes of vascular occlusion which is usually diagnosed as "chronic thromboembolic pulmonary hypertension" and that venous throm boembolism is unlikely to be a common cause of chronic pulmonary hypertension.
The clinical course of pulmonary embolism.
TLDR
When properly diagnosed and treated, clinically apparent pulmonary embolism was an uncommon cause of death, and it recurred in only a small minority of patients.
The clinical course of patients with suspected pulmonary embolism.
TLDR
The mortality among patients with suspected pulmonary emblism was considerable, however, most deaths were unrelated to pulmonary embolism, but were the result of serious underlying illnesses.
The Clinical Course of Patients With Suspected Pulmonary Embolism
TLDR
The mortality among patients with suspected pulmonary emblism was considerable, however, most deaths were unrelated to pulmonary embolism, but were the result of serious underlying illnesses.
Chronic thromboembolic pulmonary hypertension.
TLDR
Pulmonary arterial hypertension is a severe disease that has been ignored for a long time but over the past 20 yrs chest physicians, cardiologists and thoracic surgeons have shown increasing interest in this disease because of the development of new therapies, that have improved both the outcome and quality of life of patients.
Thrombotic risk factors in pulmonary hypertension.
TLDR
The most striking finding of this study was the high prevalence of phospholipid-dependent antibodies but their clinical relevance appears to be different in primary pulmonary hypertension and chronic thromboembolic pulmonary hypertension.
Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography.
TLDR
The pulmonary angiographic findings suggestive of chronic thromboembolic disease included "pouching" defects, webs or bands, intimal irregularities, abrupt vascular narrowing, and complete vascular obstruction.
The Long-Term Clinical Course of Acute Deep Venous Thrombosis
TLDR
The clinical course of a first episode of symptomatic deep venous thrombosis in a large consecutive series of patients who had long-term follow-up was assessed and the potential risk factors for these three outcomes were evaluated.
Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary Embolism*
TLDR
Haemodynamic and arteriographic findings after treatment for 72 hours provided an objective measurement of resolution, which was significantly greater in the streptokinase-treated patients, and there was no significant difference between the groups in terms of pretreatment haemodynamic or arteriography findings.
...
1
2
3
...